2025 first_quarter Filing
Q1Lobbying Activities
Issues related to mental health. Issues related to SUPPORT Act reauthorization. Monitored Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization. Issues related to pharmacy benefit management, including alternative funding programs. Monitored issues related to healthcare workforce shortages. Monitored issues related to drug pricing. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Monitored implementation of P.L. 117-169, the Inflation Reduction Act, as it relates to drug pricing. Monitored issues related to Ambulatory Surgical Centers. Issues related to pharmacy benefit management. Monitored issues related to Medicare physician payment. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.